Montgomery & Ponder, LLC is currently investigating claims for damages related to compulsive behavior, such as excessive gambling, for people who have taken Abilify.
Abilify is an antipsychotic drug approved to treat symptoms of schizophrenia, autistic disorder, Tourette’s disorder, and episodes of mania or mixed episodes associated with bipolar disorder. The drug works by altering the activity of certain natural substances in the brain
Abilify has been linked to pathological gambling, shopping, eating, and sex. This addictive behavior has been found to start almost immediately upon taking Abilify, and stop once the patient is switched to another medicine. The obsessive behavior caused by Abilify is such that the person develops an uncontrollable urge to perform an act (such as, gambling), and cannot resist the desire. The person will continue to do the act even if it's causing him or her personal, social and financial injuries.
The Abilify lawsuits claim that Otsuka Pharmaceutical Company and Bristol-Myers Squibb Company were negligent in creating a drug that was defectively designed and manufactured. According to allegations in hundreds of lawsuits filed, these defendants knew that Abilify caused compulsive behavior, such as compulsive gambling and spending. Additionally, the defendants allegedly failed to provide adequate instructions and warnings of the risks to the public. Currently, several hundred lawsuits against Abilify have been filed and consolidated in federal court in Florida.
If you or a loved one has suffered the above substantial financial losses from compulsive gambling following the use of Abilify, please contact our firm immediately at (205) 377-5004.